Nicole N. Davarpanah

ctDNA guiding adjuvant immunotherapy in urothelial carcinoma

Thomas Powles, Zoe J. Assaf, Nicole N. Davarpanah et al. · Nature · 2021 · 578 citations

Adjuvant Immunotherapy, Cancer Immunosurveillance, Urology +1

Adjuvant atezolizumab versus observation in muscle-invasive urothelial carcinoma (IMvigor010): a multicentre, open-label, randomised, phase 3 trial

Joaquim Bellmunt, Maha Hussain, Jürgen E. Gschwend et al. · The Lancet Oncology · 2021 · 393 citations · Full text

Urology, Versus Observation, Genitourinary Cancer +6

Phase I Study of Cabozantinib and Nivolumab Alone or With Ipilimumab for Advanced or Metastatic Urothelial Carcinoma and Other Genitourinary Tumors

Andrea B. Apolo, Rosa Nadal, Daniel M. Girardi et al. · Journal of Clinical Oncology · 2020 · 134 citations · Full text

Updated Overall Survival by Circulating Tumor DNA Status from the Phase 3 IMvigor010 Trial: Adjuvant Atezolizumab Versus Observation in Muscle-invasive Urothelial Carcinoma

Thomas Powles, Zoe J. Assaf, Viraj Degaonkar et al. · European Urology · 2023 · 112 citations

Urology, Overall Survival, Genitourinary Cancer +6

Cabozantinib in patients with platinum-refractory metastatic urothelial carcinoma: an open-label, single-centre, phase 2 trial

Andrea B. Apolo, Rosa Nadal, Yusuke Tomita et al. · The Lancet Oncology · 2020 · 88 citations · Full text

Urology, Genitourinary Cancer, Medicine +8